Mark J. Ratain to CD56 Antigen
This is a "connection" page, showing publications Mark J. Ratain has written about CD56 Antigen.
Connection Strength
0.055
-
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661. Clin Cancer Res. 2002 Dec; 8(12):3718-27.
Score: 0.055